Abstract: The rapid progression of artificial intelligence and robotics is bringing a transformation to pharmaceutical manufacturing with the potential of fully autonomous, intelligence-based ...

Elon Musk said Thursday that Tesla’s Optimus robots should be available to the public by the end of next year, after the company refines the technology. “That’s when we are confident that its very ...

On her smartphone map, she watched the tiny dot scurrying toward her Fort Lauderdale address in real time. Then her phone buzzed with an alert: “Your food delivery robot is here!” Karla Joan ...

Robots and other automation technologies could replace 20% of U.S. jobs over the next two decades, according to economists. Researchers with investment advisory firm Oxford Economics said in a report ...

North American robot orders rose in 2025, reflecting strong investment in automation across a range of industries. According to new data from the Association for Advancing Automation (A3), companies ...

Improvements to the AI that powers Unitree's H2 and G1 humanoid robots, alongside mechanical upgrades, have resulted in a dazzling kung-fu demonstration. When you purchase through links on our site, ...

The new robotic industry may have some surprise funding sources (“The Robot Revolution Is Real. Tesla, Hyundai, and More Stocks to Play It,” Cover Story, Feb. 6). For example, long-term care insurance ...

Abstract: Swarm robotics has become a radical paradigm of search and rescue (SAR) operations in disaster-prone or risky settings where humans are too risky or impracticable. This review considers the ...

Something to look forward to: Robots are beginning to see and respond in real time. A new study published in Nature Communications by researchers at Beihang University in China describes a vision ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. China has been scaling up its efforts to develop ...

Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D. Following the departure of GSK CEO Emma ...